The SmallCapRelations Newsletter Where Promising Small-cap Market Plays Meet Forward-thinking Investors

The SmallCapRelations Newsletter Newsletter Archives

SmallCapRelationsSpotlight Company

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

Investment Considerations Tonix Pharmaceuticals is poised to capitalize on the growing demand for fibromyalgia treatments with its lead candidate, TNX-102 SL, which has demonstrated strong Phase 3 clinical results and received FDA Fast Track designation. The company’s diversified pipeline, targeting CNS disorders, autoimmune diseases, and cocaine intoxication, offers multiple avenues for growth and reduces reliance … Continue reading “Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)”

View Profile

Tonix Pharmaceuticals Holding Corp.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
IBN (InvestorBrandNetwork)

SmallCapRelations is part of the IBN (InvestorBrandNetwork).

SmallCapRelations (SCR) exists to enhance the communication between public entities and stakeholders through accurate, timely and informative messaging solutions. We also specialize in the unique communication needs of private companies planning to go public. With a substantial staff of corporate communication professionals, SCR builds a framework that rapidly conveys your brand's messaging to potential shareholders, clients, analysts, media and the general public.

Other brands within the network include:
CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SeriousTraders
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo